{
    "clinical_study": {
        "@rank": "55154", 
        "arm_group": [
            {
                "arm_group_label": "Soak and smear", 
                "arm_group_type": "Active Comparator", 
                "description": "Application of hydrocortisone 2.5% ointment or triamcinolone acetonide 0.1% ointment immediately to wet skin once a day and dry skin once a day."
            }, 
            {
                "arm_group_label": "Dry smear", 
                "arm_group_type": "Active Comparator", 
                "description": "Application of hydrocortisone 2.5% ointment or triamcinolone acetonide 0.1% ointment to dry skin twice a day."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the efficacy of two different corticosteroid\n      ointment application regimens for the treatment of eczema (atopic dermatitis)."
        }, 
        "brief_title": "A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Atopic Dermatitis", 
        "condition_browse": {
            "mesh_term": [
                "Dermatitis", 
                "Dermatitis, Atopic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Meet the clinical criteria for the diagnosis of atopic dermatitis\n\n          -  Have disease over at least 5% of their total body surface area.\n\n          -  Less than 18 years of age.\n\n          -  Families able to comprehend written instructions in English and able to complete\n             questionnaires with assistance if needed.\n\n          -  Parents/guardians able to understand and willing to sign a parental permission form.\n\n          -  Children between the ages of 7-17 years willing to sign an age-appropriate assent\n             form.\n\n        Exclusion Criteria:\n\n          -  Patients who are allergic or intolerant of the topical medications employed in this\n             study.\n\n          -  Lack of follow-up after initial visit or regimen noncompliance.\n\n          -  Patients who do not have access to a bathtub."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01675232", 
            "org_study_id": "HIC-1206010366"
        }, 
        "intervention": [
            {
                "arm_group_label": "Soak and smear", 
                "description": "Corticosteroid ointment applied to wet skin once a day and dry skin once a day.", 
                "intervention_name": "Soak and smear", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Dry smear", 
                "description": "Corticosteroid ointment applied to dry skin twice a day.", 
                "intervention_name": "Dry Smear", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atopic dermatitis", 
            "Topical corticosteroid", 
            "Pediatric", 
            "Eczema"
        ], 
        "lastchanged_date": "January 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06510"
                }, 
                "name": "Yale University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Investigator-Blinded Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis", 
        "overall_contact": {
            "email": "Lucinda.Liu@yale.edu", 
            "last_name": "Lucinda Liu, BA"
        }, 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Richard J Antaya, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Efficacy of corticosteroid application regimen as assessed by the Eczema Area and Severity Index (EASI)", 
            "safety_issue": "No", 
            "time_frame": "2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01675232"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Richard Antaya", 
            "investigator_title": "Professor of Dermatology and Pediatrics", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Effect of corticosteroid ointment application regimens on serum cortisol", 
                "safety_issue": "Yes", 
                "time_frame": "2 weeks after application of topical corticosteroids"
            }, 
            {
                "measure": "Frequency of atopic dermatitis flares in the 3 months following the two-week treatment regimen", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Characterize and quantify adverse effects associated with each corticosteroid application regimen.", 
                "measure": "Adverse effects associated with each corticosteroid application regimen", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}